Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 290
Selected: 0
NCT IDTitle
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT04466098Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
NCT03789721Adrenoleukodystrophy National Registry Study
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT03054909IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT05708703Assessing the Time Demands of Cancer
NCT00400803Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
NCT02141451ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
NCT03981705Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT03850704Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT06030648MT2022-01: MSCs for ALD
NCT00871689Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
NCT03978117Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT04530695Diagnosis and Treatment of Periodontal Disease in Patients With AML
NCT02145039Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT05634512Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
NCT02988843Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
NCT01626092Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT00376805Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
NCT01009437Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT00686556Total Marrow Irradiation for Refractory Acute Leukemia
NCT03367546Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT00352976TBI Dose De-escalation for Fanconi Anemia
NCT00176917Stem Cell Transplantation for Hurler
NCT03152526CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
NCT06594445HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
NCT06411795Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT05705700Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
NCT02765997StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT00478244Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
NCT06322992App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
NCT03213964Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
NCT00167206Stem Cell Transplantation for Fanconi Anemia
NCT00775931Allogeneic Transplantation For Severe Osteopetrosis
NCT04225572Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
NCT06295757Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
NCT00617929Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer